NEW YORK (360Dx) – The US Food and Drug Administration today issued a draft guidance that provides recommendations on testing for biotin interference with in vitro diagnostic devices.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.